The Patent Finder

Sinphar Pharmaceutical Co., Ltd.

8 patents currently held · Updated Nov 21, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 2 name spellings.

0
Ending by 2030
Aug 2031
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due May 26, 2027
    The maintenance fee for Anti-Fatigue Composition Used for Increasing Endurance Performance, and Use of the Same (US 10,485,836) comes due May 26, 2027. Unpaid by Nov 26, 2027, it lapses early.
  • 1 fee due Nov 17, 2027
    The maintenance fee for Method for Regulating Blood Glucose Level (US 9,339,522) comes due Nov 17, 2027. Unpaid by May 17, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 8 of 8

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 9,757,392Pharmaceutical composition and extract of Poria for enhancing uptake of nutrients
In force
 · USPTO record
In forceUSPTO record
US 9,339,522Method for Regulating Blood Glucose Level
In force
 · High confidence
In forceHigh confidence
US 9,993,509Method for Regulating Blood Glucose Level
In force
 · High confidence
In forceHigh confidence
US 9,370,540K2 Composition and the Preparation Method and Use of the Same
In force
 · High confidence
In forceHigh confidence
US 10,973,863Method for Regulating, Preventing And/Or Treating Pulmonary Injury
In force
 · High confidence
In forceHigh confidence
US 10,967,029Method of using Cistanche tubulosa extract to prevent, slow down, or treat an eye disease caused by oxidative stress
In force
 · USPTO record
In forceUSPTO record
US 11,654,169Methods for Protecting Skin And/Or Promoting Wound Healing
In force
 · High confidence
In forceHigh confidence
US 10,485,836Anti-Fatigue Composition Used for Increasing Endurance Performance, and Use of the Same
In force
 · High confidence
In forceHigh confidence
Also on record, not counted in the 8: 2 lapsed for an unpaid fee · 2 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

1 abandoned · 8 no status recorded

Showing 1 to 9 of 9, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.

ApplicationTitleFiledStatus
15/591,261Uses of Poria Cocos Epidermis Extract, Poricoic Acid a, and Poricoic Acid B in Regulating Blood Glucose LevelMay 10, 2017Abandoned
14/790,017Jul 2, 2015No status recorded
14/683,231Apr 10, 2015No status recorded
12/838,545Jul 19, 2010No status recorded
12/473,110May 27, 2009No status recorded
12/081,147Apr 11, 2008No status recorded
11/452,302Jun 14, 2006No status recorded
11/126,225May 11, 2005No status recorded
10/717,559Nov 21, 2003No status recorded
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited